血清氨基酸在高尿血症中的改变:预防病的潜在目标
Qinglin Sheng1, Yuqing Ma2, Bingjie Geng2
1University of Shanghai for Science and Technology, Shanghai, 200093, China.
Amino acids
|February 18, 2025
概括
高尿酸 (UA) 水平与脏疾病和氨基酸代谢改变有关. 氨酸特别调解了UA和功能障碍之间的关系,这表明它是潜在的治疗标.
科学领域:
- 生物化学 生物化学
- 腎臟病學 (nephrology) 是一種醫學.
- 代谢学 代谢学 代谢学
背景情况:
- 观察性研究表明,尿酸 (UA) 水平,氨基酸平衡和病之间存在联系.
- 增加UA,氨基酸变化和功能障碍之间的确切因果关系尚不清楚.
研究的目的:
- 为了调查是否升高的UA影响循环氨基酸水平.
- 为了确定氨基酸是否调解UA和病之间的关系.
- 阐明UA,氨基酸和脏疾病之间的因果关系.
主要方法:
- 利用Uox-KO小鼠进行超尿血的模型.
- 通过血液生物化学和组织病理学评估损伤.
- 使用目标代谢学分析了血清氨基酸概况.
- 使用门德尔的随机化推断因果关系.
主要成果:
- 在Uox-KO小鼠中,高尿路血导致UA升高,功能障碍标志物和组织损伤显著.
- 观察到血清氨基酸平衡的变化,标明了氨酸,异黄氨酸,白氨酸,青酸,氨酸,谷氨酸和甘氨酸作为关键代谢物.
- 基因预测UA与慢性功能衰竭 (CRF) 和血液尿素 (BUN) 有正相关,与eGFRcys和eGFRcrea有负相关.
- 发现氨酸 (Ala) 可以调节UA对CRF和BUN风险升高的影响.
结论:
- 血清氨基酸的代谢变化发生在高尿血症中.
- 基因预测UA与不良的结局 (CRF,BUN) 和降低功能 (eGFRcys,eGFRcrea) 相关.
- 氨酸调解了UA对CRF和BUN的影响,突出了其作为预防高尿血症诱导脏疾病的治疗标的潜力.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
Antihypertensive Drugs: Action of Diuretics
613
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
613
Antihypertensive Drugs: Direct Renin Inhibitors
474
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
474
Physiology of Urine Formation
2.7K
Urine formation is an essential function of the human body. It plays a critical role in maintaining homeostasis by regulating the volume and composition of body fluids. The kidneys, the primary organs involved in this process, filter blood to remove waste products and excess substances, ultimately producing urine.
Glomerular Filtration
The first stage in urine formation is glomerular filtration. Each kidney contains approximately 1 million nephrons, the functional units of filtration, with a...
Glomerular Filtration
The first stage in urine formation is glomerular filtration. Each kidney contains approximately 1 million nephrons, the functional units of filtration, with a...
2.7K
Renal Failure: Dose Adjustments
60
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
60
Renal Drug Excretion: Tubular Secretion
105
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
105
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)

